Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Screening Considerations: Balancing the Benefits and Risks

Caring for a Loved One with Cancer

Cancer Prognosis

Microfluidic cancer treatment screen combined with flow cytometry

CDK9 and Cancer

Secondary Lung Cancer

What is the Tumor Microenvironment?

Cancer History

Cancer Pain

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Hot vs Cold: the differences between tumor types

See more featured articles »

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Secondary Brain Cancer

Living with Cancer Pain

Acidosis and Tumor Progression

Cutaneous Manifestations of Internal Malignancy

The Effects of Cancer on Family Life

What is Cancer of Unknown Primary?

The Cancer Cell Surface Proteome as a Therapeutic Target

The Biochemistry of Breast Cancer Screening

Pediatric Cancer

Cancer Symptoms

Cancer Epidemiology

Insight into Cancer Vaccines

Assay for Monitoring and Treating Malignant Brain Tumors

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Diagnosis

Cancer Pain Management

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Is Cancer a Metabolic Disorder?

Cancer Research

What is Merkel Cell Carcinoma?

Myc Mutations and Cancer

What Causes Cancer?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Insights into Oncofertility

Effects of Social and Economic Deprivation on Cancer Mortality

What is Tumorigenesis?

Hypoxia Markers and Their Importance

Using Biomarkers to Detect Cancer

What is Cancer?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

British Pioneers in Cancer Biology

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What is Immunochemotherapy?

Investigating the Molecular Mechanisms of Cancer

Cancer Management

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Prevention: Lowering your Risk

Extracellular Vesicles as Floating Cancer Biomarkers

Targeted Cancer Therapies

Cancer Pathophysiology

What Role do Biobanks Play in Cancer Research?

Cancer Classification

Cancer Glossary

Overview of Cell Viability and Cytotoxicity

Transforming Cancer Care through Genomic Testing

Why are Cancer Cell Lines Useful?

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Latest Cancer News and Research

New nanoparticles disable drug resistance to achieve complete tumor elimination

Cancer cells frequently develop the ability to expel anticancer drugs before they can work -- a phenomenon called multidrug resistance (MDR) -- which is one of the leading reasons why chemotherapy fails in patients.

8 May 2026

The power of organoids in speeding up lifesaving drug development

Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult stem cells, etc.) or progenitor cells in an in vitro three-dimensional culture system, which possess structural features and partial functions analogous to their corresponding in vivo organs. In 2009, the Hans Clevers laboratory developed the first intestinal organoid, marking the inception of organoid-based disease modeling.

8 May 2026

Prisoners in England face dramatically higher rates of avoidable healthcare harms

Prisoners in England are 41 to 67 times more likely to experience avoidable harms as a result of poor healthcare than the general public, suggest the findings of a case note review of medical records, published online in the journal BMJ Quality & Safety.

8 May 2026

Legumes and soy foods may help reduce hypertension risk

A higher dietary intake of soy and legumes is linked to a lower risk of high blood pressure, finds a pooled data analysis of the available evidence, published in the open access journal BMJ Nutrition Prevention & Health.

8 May 2026

Diverse leukemia stem cells may drive AML relapse after therapy

Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML).

7 May 2026

Long telomeres linked to higher lymphoma risk in families

Researchers at the Johns Hopkins Kimmel Cancer Center and the Telomere Clinic at Johns Hopkins have identified a genetic syndrome in which unusually long telomeres - the protective caps at the ends of chromosomes - allow immune cells to remain biologically "younger" for longer than normal, predisposing affected individuals to lymphoma and other cancers.

7 May 2026

Chromosome abnormalities may help cancer cells resist treatment and spread

A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have an abnormal number of chromosomes, which are DNA strands wound up in bundles that control which genetic instructions are followed in each cell type.

7 May 2026

JAYseq test delivers rapid genomic profiling for multiple myeloma patients

The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of JAYseqTM, a clinical whole-genome sequencing (WGS) test specifically for multiple myeloma.

7 May 2026

Many metastatic lung cancer patients still receive no treatment options

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in options over recent decades that have created meaningful improvements in lifespan and quality of life for many patients.

7 May 2026

Heart disease risk prediction tool proves effective across global populations

A tool developed by the American Heart Association (AHA), proven to accurately predict heart disease risk for Americans, can be applied to the global population, a new study led by NYU Langone Health shows.

7 May 2026

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Menopause symptoms like hot flushes can be debilitating. Dr. Katie Barber highlights new treatments, including fezolinetant, for improved patient care.

7 May 2026

A new combined therapy to boost the immune system against cancer

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak or too slow to be effective.

7 May 2026

New AI model spots hidden pancreatic cancer long before diagnosis

Mayo Clinic's AI model identifies invisible signs of pancreatic cancer on routine CT scans, potentially transforming early detection and survival rates.

7 May 2026

The importance of genetic screening for all cancer survivors

Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are just as likely as those diagnosed today to carry a germline pathogenic variant (gPV) - a heritable genetic alteration - that increases cancer risk.

7 May 2026

Birth weight predicts kidney function during endurance exercise

Researchers investigate how birth weight determines kidney function changes following prolonged physical activity in different environmental conditions.

7 May 2026

Targeted RAS inhibitor shows promise against pancreatic cancer mutations

The targeted RAS inhibitor therapy daraxonrasib demonstrated the potential to improve patient outcomes over current standard treatments for patients with RAS-mutant pancreatic cancer, according to results of a Phase 1/2 trial led by researchers at The University of Texas MD Anderson Cancer Center.

7 May 2026

Reverse ecology approach reveals hidden complexity in gut microbiome

The human gut harbors a complex ecosystem of trillions of microorganisms (the microbiome), which influences digestion, the immune system and metabolism.

7 May 2026

Researchers identify new treatment vulnerabilities in pancreatic cancer progression

The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to treatment, and where new hope may emerge.

6 May 2026

New CRISPR system selectively destroys cancer cells

Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other pathologies, without destroying healthy tissue.

6 May 2026

New immunotherapy strategy overcomes resistance in colorectal cancer treatment

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a promising new strategy to overcome resistance to immunotherapy in colorectal cancer, one of the leading causes of cancer-related deaths worldwide.

6 May 2026